The Reprove trial evaluated the efficacy of Zavicefta compared to meropenem in the treatment of adult patients with hospital-acquired pneumonia, including ventilator-associated pneumonia. The antibiotic met the primary
Apex’s lead drug candidate APX3330 is a small molecule that targets the redox effector factor-1 (Ref-1) protein which regulates the activation of oncogenic transcription factors. The first part
CHI refers to several congenital disorders in which hypoglycemia is caused by excessive insulin secretion. Itis a rare genetic disorder in which the insulin cells of the pancreas
The equity stake is part of an agreement under which Shire granted three central nervous system (CNS) pre-clinical development programs to Chronos in return for milestones and an
The 280,000ft² facility will serve as a major hub for the North American life science business of Merck. It will feature a customer collaboration laboratory and training center
Progenics Pharmaceuticals licensed development and commercialization rights for the product to Valeant Pharmaceuticals International. Valeant anticipates to starts sales of Relistor tablets in the US in the third
Qtern is a fixed-dose combination of saxagliptin and dapagliflozin, two oral blood glucose lowering medicines, indicated in adults aged 18 years and older with type 2 diabetes. It intends to
The reference product is approved in the European Union for use in moderate to severe rheumatoid arthritis (RA), ankylosing spondylitis, moderate to severe plaque psoriasis, active and progressive
Tiziana bought the biobank as well as other key assets from Cagliari-based biobanking and genomics research firm Shardna for a total of €258,000. The acquisition allows Tiziana to
The projected FDA’s action date is 11 November, while the EMA's centralized review process is underway. The data supporting both applications were generated in the phase 3 Checkmate-141
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.